Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
Public ClinicalTrials.gov record NCT00894647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Imiquimod Cream Following Cryosurgery for the Treatment of Actinic Keratoses
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the efficacy and safety of imiquimod cream versus placebo cream when used after cryosurgery in the treatment of actinic keratoses (AKs).
Study identification
- NCT ID
- NCT00894647
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 247 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2009 (Type not available)
- Primary completion
- Feb 2010 (Actual)
- Completion
- Feb 2010 (Actual)
- Last update posted
- Aug 31, 2010
2009 – 2010
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Spencer Dermatology & Skin Surgery Center | Saint Petersberg | Florida | 33705 | — |
| Palm Beach Dermatology | West Palm Beach | Florida | 33401 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Evanston Northwestern Healthcare | Skokie | Illinois | 60077 | — |
| Skin Specialists PC | Omaha | Nebraska | 68144 | — |
| Academic Dermatology Association | Albuquerque | New Mexico | 87106 | — |
| DermResearchCenter of New York | Stony Brook | New York | 11790 | — |
| Wake Forest Univ School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| DermResearch Inc. | Austin | Texas | 78759 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
| Progressive Clinical Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00894647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2010 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00894647 live on ClinicalTrials.gov.